Back
Editas Medicine Quote, Financials, Valuation and Earnings
Sponsored
EDIT
Sponsored
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
EDIT
Editas Medicine
Last Price:
3.39
Seasonality Move:
22%
7 Day Trial
ALL ACCESS PASS
$
7
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn MoreEditas Medicine Price Quote
$3.39
+0.01 (+5.77%)
(Updated: October 5, 2024 at 6:26 AM ET)
Editas Medicine Key Stats
Sell
38
Editas Medicine (EDIT)
is a Sell
Day range:
$3.25 - $3.48
52-week range:
$3.15 - $11.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.13
P/B ratio:
1.2%
Volume:
3.1M
Avg. volume:
2M
1-year change:
-52.06%
Market cap:
$278.8M
Revenue:
$78.1M
EPS:
$-2.36
How Much Does Editas Medicine Make?
-
How Much Are Editas Medicine's Sales Annually?
EDIT Revenues are $78.1M -
How Much Profit Does Editas Medicine's Make A Year?
EDIT net income is -$153.2M
Is Editas Medicine Growing As A Company?
-
What Is Editas Medicine's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.82% -
What Is Editas Medicine's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Editas Medicine Stock Price Performance
-
Did Editas Medicine Stock Go Up Last Month?
Editas Medicine share price went down by -3.43% last month -
Did EDIT's Share Price Rise Over The Last Year?
EDIT share price fell by -52.06% over the past 1 year
What Is Editas Medicine 52-Week High & Low?
-
What Is Editas Medicine’s 52-Week High Share Price?
Editas Medicine has traded as high as $11.69 over the past 52 weeks -
What Is Editas Medicine’s 52-Week Low Share Price?
Editas Medicine has traded as low as $3.15 over the past 52 weeks
Editas Medicine Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Editas Medicine?
-
How Much Debt Does Editas Medicine Have?
Total long term debt quarterly is $0 -
How Much Cash Does Editas Medicine Have?
Cash and short term investments quarterly total is $279.1M -
What Is Editas Medicine’s Book Value Per Share?
Book value per share is 2.81
Is Editas Medicine Cash Flow Positive?
-
What Is EDIT Cash Flow From Operations?
Cash flow from operations (TTM) is -$164.6M -
What Is Editas Medicine’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1M -
What Is Editas Medicine’s Cash Flow From Investing?
Cash flow from investing (TTM) is $7.2M
Editas Medicine Return On Invested Capital
-
Is Management Doing A Good Job?
EDIT return on invested capital is -59.13% -
What Is Editas Medicine Return On Assets?
ROA measures how assets are converting to revenues and is -40.8% -
What Is EDIT Return On Equity?
ROE is a measure of profitability and is -59.13%
Editas Medicine Earnings Date & Stock Price
-
What Is Editas Medicine's Stock Price Today?
A single share of EDIT can be purchased today for 3.38 -
What Is Editas Medicine’s Stock Symbol?
Editas Medicine trades on the nasdaq under the ticker symbol: EDIT -
When Is Editas Medicine’s Next Earnings Date?
The next quarterly earnings date for Editas Medicine is scheduled on November 1, 2024 -
When Is EDIT's next ex-dividend date?
Editas Medicine's next ex-dividend date is October 5, 2024 -
How To Buy Editas Medicine Stock?
You can buy Editas Medicine shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Editas Medicine Competitors
-
Who Are Editas Medicine's Competitors?
Below is a list of companies who compete with Editas Medicine or are related in some way:
Editas Medicine Dividend Yield
-
What Is EDIT Dividend Yield?
Editas Medicine’s dividend yield currently is 0% -
What Is Editas Medicine’s Payout Ratio?
Editas Medicine’s payout ratio is 0% -
When Did Editas Medicine Last Pay A Dividend?
The latest dividend pay date is October 5, 2024 -
What Is Editas Medicine’s Dividend Per Share?
Editas Medicine pays a dividend of $0.00 per share
Editas Medicine Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -14.77% |
Revenue: | -82.23% | -87.62% |
Analyst Recommendations
Buy Recommendations: | 9 |
---|---|
Hold Recommendations: | 9 |
Sell Recommendations: | 0 |
Price Target: | 13.50 |
Upside from Last Price: | 299.41% |